Viruses have evolved a broad range of strategies that enable them to evade the immune systems of their hosts. A team of researchers at the Max von Pettenkofer Institute at LMU Munich led by virologist Jürgen Haas has been studying a novel, recently discovered mechanism that pathogenic viruses exploit for this purpose, and their latest results could point the way to new antiviral therapies.
The mechanism is based on the production of short RNA molecules, called microRNAs, by the virus. RNA is chemically related to the genetic material DNA, and full-length RNA copies of gene sequences specify the structures of all cell proteins. MicroRNAs (miRNAs), on the other hand, play a crucial role in regulating gene expression.
"Viruses use them to regulate the expression not only of their own genes, but also of host genes," says Haas. "Because human cells also produce regulatory miRNAs, the viral molecules do not provoke an immune response." Haas and his team, in cooperation with several other groups in Germany and abroad, have now identified 158 human genes that are targeted by miRNAs synthesized by two types of herpesvirus that can cause cancer in humans. "Our findings provide fundamental insights into the functions of viral miRNAs," according to Haas. "The viral genes that encode miRNAs could offer points of attack for targeted, and urgently needed, antiviral agents."
Gene regulation, the biological process by which genes are turned on and off, is a fundamental element of cell function. A gene is a defined segment of the double-stranded genomic DNA. When a gene is active, the sequence of such a segment is transcribed from one DNA strand into RNA copies. The RNAs known as messenger RNAs (mRNAs) specify the sequences of all the proteins required by a given cell type by a second process known as translation. The proteins made by a cell determine its structure and function, so the appropriate proteins must be produced in the correct amounts and at the right time. Gene expression is therefore strictly controlled. In recent years it has become clear that short RNAs known as microRNAs (miRNAs) play a crucial role in this process in most organisms. The sequences of miRNAs are "complementary" to parts of mRNAs, and bind to them to form partially double-stranded structures. This prevents synthesis of the corresponding proteins and may lead to the degradation of the mRNAs. It is estimated that the expression of 20 percent to 30 percent of all human genes is regulated in this way. "The system acts as a sensitive regulator for fine tuning of many cell functions,” says Haas. "It is also essential for proper tissue development."
